Nadia F. Altomare

About Nadia F. Altomare

As an innovative and visionary healthcare business leader who drives paradigm changes, I have a proven executive management track record and 20 years of experience driving value creation and raising capital in the biotech and diagnostics sectors. Throughout my career, I have achieved an impressive list of firsts in bringing novel products to market. I am a forward thinker on commercialization strategies, operational infrastructure, and strategic partnerships that has contributed to the success of numerous business ventures. I am sought out for insight on go-to-market approaches that drive revenue and market ownership. Currently, I am the Chief Commercial Officer of Sera Prognostics Inc, a leader in high-value women’s health diagnostics. I am focused on its breakthrough diagnostics product where I architected and lead the commercialization strategy and execution, implementing the building blocks for widespread payer coverage and market adoption while supporting fundraising activities.Previously, as President and then CEO and member of the Board of Directors at Abcodia Ltd, a clinical-stage company engaged in using human serum-based biomarkers to develop validated tests for the early detection of cancer, I set up the U.S. subsidiary and oversaw the subsequent launch of global commercial operations. I directed a series of operational reengineering, regulatory compliance, organization restructuring, strategic planning, and other activities.Prior to Abcodia, I was Vice President & General Manager at ThermoFisher Scientific, a multinational biotechnology product development company where I turned around an under-performing business that was suffering market share losses and revenue growth decline. Among my accomplishments was the startup, build & scale of the ViaCord division.I am currently on the Board of Savran Technologies, a private healthcare company focused on enabling the next generation of non-invasive diagnostics. Previously I served on the Board of Abcodia, a women’s health diagnostics company, in both non-executive & executive director roles. I also served as the PerkinElmer representative to the Boston Chapter of the March of Dimes Board. I am available to travel and/or relocate. LDT/FDA Regulatory Environment Commercialization Build and/or Scale Organizations Turnarounds Global Expansion Product Launch & Go-to-Market Strategies Stakeholder Engagement Culture Building Scientific, Strategic & Business Acumen Inspirational Motivator Influencer Talent Magnet

Experience

1. Board of Directors

   Savran Technologies Inc

   Aug 2019 — Present · Boston, MA, US

   Savran Technologies is a private company that has developed a first-in-class patented platform for isolating rare cells from blood samples enabling the next generation of non-invasive diagnostics.

Education

• Stony Brook University

  Bachelor’s Degree, International Business

  1988 — 1991

• Northeastern University

  Master of Business Administration (M.B.A.), International Business

  1993 — 1995

Skills

• Clinical Research
• Strategy
• Mergers & Acquisitions
• Entrepreneurship
• Visionary, Big-Picture Leadership
• Team Building
• Management
• Forecasting
• Operations Improvements
• Team Management
• Training
• Continuous Process Improvement
• Advisory Boards
• Laboratory
• Cross-Cultural Communication Skills
• Human Resources
• Information Technology
• Sales Management
• Change Management
• Team Leadership
• Cross Functional Team Building
• Healthcare
• Manufacturing
• B2b
• Growth Strategies
• Executive Management
• Business Planning
• Operations Management
• B2c Marketing
• Contract Negotiation
• Start-Ups
• Full P&L Accountability
• Client & Partner Relationships
• Strategic Partnerships
• Lead Generation
• Infectious Diseases
• Long & Short Term Strategic Planning
• Global Business Strategy
• Biotechnology
• Technical Support